For the latter, elevated HbA2 levels of 10.7% (SD = 2.0%) potentially implicate a diagnosis of combined SUPT5H/HBB in beta-thalassemia carriers expressing beta-thalassemia intermedia. This evidence concerns the gene HBB and beta-thalassemia intermedia.